Research & Education

IASLC Global Survey for Pathologists on Immune Biomarkers in Lung Cancer

As part of an IASLC project aiming to gain more information about the prevalence and practices of PD-L1 testing in lung cancer patients throughout the world, we invite pathologists to take a 10-minute survey.

Your participation is very important! Your answers will help us understand the current status of PD-L1 testing in lung cancer and improve the PD-L1 testing practice globally.

To encourage participation, we are giving away 5 free memberships! All respondents who complete this survey may enter for a chance to win!

For more information about this important activity, please feel free to email or dial +1.720.598.1954.

To participate in this survey, please click here.


*If you are a lung cancer patient, survivor or researcher, we encourage you to participate in the online Lung Cancer Registry. The Registry is a repository of lung cancer patients’ medical information compiled to allow for quick analysis of patient data by researchers and patients/survivors. To learn more and be part of the Lung Cancer Registry, please click here.